Bing

SEARCH HISTORY

As CEOs buy a record amount of stock with shareholder money, they are keeping their wallets in their pockets when it comes to purchasing shares with their own cash. In the last six weeks, U.S. companies made buyback announcements that came to $5.
CNBC · ByJohn Melloy · 5/18/2015
Biogen Idec Inc. /quotes/zigman/91573/delayed /quotes/nls/biib BIIB dropped nearly 5% even though it said it obtained approval in Canada for a hemophilia treatment. For Biogen, that meant a much greater drop in value than Exact with shares down more …
Market Watch Commentary · ByRuss Britt · 3/21/2014
However, profits fell 13% over the period. Under Armour stock lost 4.83% on April 21. The company surpassed Adidas to become the second largest sportswear brand after Nike (NKE). Currently, Under Armour is bearing the brunt of the currency wars.
Market Realist · 4/22/2015
More from Bing News
Assets are the company’s year-end total. Total stockholders’ equity is the sum of all capital stock, paid-in capital, and retained earnings at the company’s year-end. Excluded is equity attributable to noncontrolling interests. Also excluded is ...
FORTUNE · 6/4/2015
sector selection in utilities appears to be performing well while stock selection in the segment appears to be slightly underperforming. Mutual fund performance relative to stock selection in industrials, health care and Staples, Inc. (NASDAQ:SPLS ...
Value Walk · 2/27/2015
Read it carefully before investing. Distributed by U.S. Global Brokerage, Inc. Stock markets can be volatile and can fluctuate in response to sector-related or foreign-market developments. For details about these and other risks the Holmes Macro Trends ...
Stockhouse · 7/29/2014
CBIZ, Inc. (NYSE:CBZ) has entered into two privately negotiated exchange agreements pursuant to which it has issued 1,529,323 shares of its common stock, par value $0.01 per share (“Common Stock”), and paid additional cash consideration in …
Property Mentor Group · 6/24/2015
Copaxone’s latest rival is Tecfidera, made by Biogen Idec Inc. (Nasdaq: BIIB), which had $280 million in sales in the third quarter, $50 million more than the analysts’ forecasts. Analysts have marked Tecfidera as a blockbuster, which will reach $3 ...
Jewish Business News · 10/31/2013
This hints at the existence of unmet need for new therapies in this market. We note that Isis Pharma has an agreement with Biogen BIIB for the development and commercialization of ISIS-SMNRx for the treatment of SMA. While Isis is responsible for the ...
Yahoo News · 6/23/2015
But it's something most people will go to great lengths to avoid. So let me tell you why you should first calculate these four things every time you buy another stock. What you'll find below is a nearly foolproof way to evaluate the quality and the value ...
Daily Wealth · ByPorter Stansberry · 6/24/2015

Biogen Idec

Company
Biogen is a global biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and deliver…
Biogen is a global biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide.
Data from: Wikipedia · Freebase